GC Medical Science
₩3,215
2
+₩80+2.55% Friday 06:30
Statistics
Day High
3,215
Day Low
3,215
52W High
6,660
52W Low
2,200
Volume
-
Avg. Volume
-
Mkt Cap
69.9B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Dividends
0%Dividend Yield
Mar 15
₩50
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
31DecExpected
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-323.26
-204.42
-85.58
33.27
Expected EPS
N/A
Actual EPS
-284.6678
Financials
3.38%Profit Margin
Profitable108.41BRevenue
3.67BNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Seegene
096530.KQ
Mkt Cap1.3T
Celltrion Health Care
091990.KQ
Mkt Cap11.33T
Sillajen
215600.KQ
Mkt Cap286.62B
About
GC Medical Science Corporation operates as a diagnostic medical device company in the vitro diagnostic industry in South Korea and internationally. The company's products include human healthcare products for the diagnosis of diabetes, non-communicable diseases, respiratory diseases, and vector borne diseases. It offers CERA-CHEK 1Code and CERA-CHEK 1070 for diabetes; GREENCARE A1c for HbA1c, CERA-CHEK 3 in 1 GHL for multi-diagnosis; CERA-CHEK Lactate; GREENCARE Hb and CERA-CHEK Hb Plus for haemoglobin; and GCare Lipid and GCare Lipid Printer for cholesterol. The company also offers Covid-19 and flu diagnosis equipment including GENEDIA W Covid-19 Ag, GreenCare FLU2 Influenza A&B Ag, and " GENEDIA W Covid-19 & Flu A&B Ag. Additionally, it offers dengue diagnosis equipment including GENEDIA W Dengue NS1 Ag, GENEDIA W Dengue lgM/lgG Ab, and GENEDIA W Dengue NS1 & lgM/lgG Combo. Further, the company provides vet healthcare products, such as CERA-PET blood glucose monitoring system for diabetes; and CERA-PET Multi for non-communicable diseases diagnosis. The company was formerly known as Green Cross Medical Science Corporation and changed its name to GC Medical Science Corporation in May 2026. GC Medical Science Corporation was founded in 1972 and is headquartered in Yongin-Si, South Korea.
Show more...
CEO
Sagong Younghee
Employees
117
Country
South Korea
ISIN
KR7142280007
Listings
0 Comments
Share your thoughts
FAQ
What is GC Medical Science stock price today?▼
The current price of 142280.KQ is ₩3,215 KRW — it has increased by +2.55% in the past 24 hours. Watch GC Medical Science stock price performance more closely on the chart.
What is GC Medical Science stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange GC Medical Science stocks are traded under the ticker 142280.KQ.
Is GC Medical Science stock price growing?▼
142280.KQ stock has risen by +5.58% compared to the previous week, the month change is a +19.74% rise, over the last year GC Medical Science has showed a -18.71% decrease.
What is GC Medical Science market cap?▼
Today GC Medical Science has the market capitalization of 69.9B
What were GC Medical Science earnings last quarter?▼
142280.KQ earnings for the last quarter are -284.67 KRW per share, whereas the estimation was N/A KRW resulting in a N/A surprise. The estimated earnings for the next quarter are N/A KRW per share.
What is GC Medical Science revenue for the last year?▼
GC Medical Science revenue for the last year amounts to 108.41B KRW.
What is GC Medical Science net income for the last year?▼
142280.KQ net income for the last year is 3.67B KRW.
Does GC Medical Science pay dividends?▼
Yes, 142280.KQ dividends are paid annual. The last dividend per share was 50 KRW. As of today, Dividend Yield (FWD)% is 0%.
How many employees does GC Medical Science have?▼
As of September 05, 2026, the company has 117 employees.
In which sector is GC Medical Science located?▼
GC Medical Science operates in the Health & Wellness sector.
When did GC Medical Science complete a stock split?▼
GC Medical Science has not had any recent stock splits.
Where is GC Medical Science headquartered?▼
GC Medical Science is headquartered in Yongin-Si, South Korea.